Get startedLog in
    Picture of SynAct Pharma AB logo

    SYNACT — SynAct Pharma AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapSucker Stock
    All News

    Brief: Synact Pharma Carries Out Directed Issue And Fully-Guaranteed Rights Issue

    Picture of SynAct Pharma AB logoSynAct Pharma AB
    21/10/2019 08:28
    Oct 21 (Reuters) - SynAct Pharma AB  SYNACT.TE :
    * CARRIES OUT DIRECTED ISSUE AND FULLY-GUARANTEED RIGHTS
ISSUE
WITH AIM OF INCREASING COMMERCIAL VALUE OF AP1189
    * TOTAL PROCEEDS FROM DIRECTED ISSUE AND RIGHTS ISSUE TO
AMOUNT TO
AROUND SEK 63.1 MILLION BEFORE ISSUE COSTS

Source text for Eikon:  ID:nWkr3TXpW8 
Further company coverage:  SYNACT.TE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

    Recent news on SynAct Pharma AB

    See all news